Table 9. Other tumors summary (N = 2).

Study name (year)	Study type/size	HALP threshold (method)	Outcome(s)	Summary
The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel prognostic factor for patients with diffuse large B-cell lymphoma; Vlatka et al., (2022)	Retrospective N = 153	20.8 (ROC)	5-year OS and EFS in newly diagnosed diffuse large B-cell lymphoma patients treated with R-CHOP.	Patients with Low HALP <20.8 has worse 5-year survival. Low HALP was also associated with several worse prognostic clinical and pathological factors.
The clinical significance of perioperative inflammatory index as a prognostic factor for patients with retroperitoneal soft tissue sarcoma; Matsui et al., (2022)	Retrospective N = 113	3.0 (Median)	OS in patients with retroperitoneal soft tissue sarcomas undergoing tumor resection.	Low HALP <3 was not associated with worse overall survival, although HALP was associated with worse overall survival in a subset of De-differentiated liposarcoma patients.